Literature DB >> 12925685

Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing.

Mariano A Garcia-Blanco1.   

Abstract

In the human genome, the majority of protein-encoding genes are interrupted by introns, which are removed from primary transcripts by a macromolecular enzyme known as the spliceosome. Spliceosomes can constitutively remove all the introns in a primary transcript to yield a fully spliced mRNA or alternatively splice primary transcripts leading to the production of many different mRNAs from one gene. This review examines how spliceosomes can recombine two primary transcripts in trans to reprogram messenger RNAs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925685      PMCID: PMC171395          DOI: 10.1172/JCI19462

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Evolutionary origin of SL-addition trans-splicing: still an enigma.

Authors:  T W Nilsen
Journal:  Trends Genet       Date:  2001-12       Impact factor: 11.639

2.  Fooling mother nature.

Authors:  Ronald G Crystal
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

Review 3.  An extensive network of coupling among gene expression machines.

Authors:  Tom Maniatis; Robin Reed
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

4.  Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?

Authors:  T Kikumori; G J Cote; R F Gagel
Journal:  Hum Gene Ther       Date:  2001-07-20       Impact factor: 5.695

Review 5.  Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing.

Authors:  A C Goldstrohm; A L Greenleaf; M A Garcia-Blanco
Journal:  Gene       Date:  2001-10-17       Impact factor: 3.688

6.  Promoter choice determines splice site selection in protocadherin alpha and gamma pre-mRNA splicing.

Authors:  Bosiljka Tasic; Christoph E Nabholz; Kristin K Baldwin; Youngwook Kim; Erroll H Rueckert; Scott A Ribich; Paula Cramer; Qiang Wu; Richard Axel; Tom Maniatis
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

Review 7.  Emerging clinical applications of RNA.

Authors:  Bruce A Sullenger; Eli Gilboa
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

8.  Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.

Authors:  Xiaoming Liu; Qinshi Jiang; S Gary Mansfield; M Puttaraju; Yulong Zhang; Weihong Zhou; Jonathan A Cohn; Mariano A Garcia-Blanco; Lloyd G Mitchell; John F Engelhardt
Journal:  Nat Biotechnol       Date:  2002-01       Impact factor: 54.908

9.  Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing.

Authors:  M Puttaraju; J DiPasquale; C C Baker; L G Mitchell; M A Garcia-Blanco
Journal:  Mol Ther       Date:  2001-08       Impact factor: 11.454

10.  Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing.

Authors:  Hengjun Chao; S Gary Mansfield; Robert C Bartel; Suja Hiriyanna; Lloyd G Mitchell; Mariano A Garcia-Blanco; Christopher E Walsh
Journal:  Nat Med       Date:  2003-07-06       Impact factor: 53.440

View more
  22 in total

Review 1.  Targeted genetic repair: an emerging approach to genetic therapy.

Authors:  Bruce A Sullenger
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 2.  Ribozyme-mediated revision of RNA and DNA.

Authors:  Meredith B Long; J P Jones; Bruce A Sullenger; Jonghoe Byun
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Molecular imaging of gene expression in living subjects by spliceosome-mediated RNA trans-splicing.

Authors:  S Bhaumik; Z Walls; M Puttaraju; L G Mitchell; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

4.  When proteome meets genome: the alpha helix and the beta strand of proteins are eschewed by mRNA splice junctions and may define the minimal indivisible modules of protein architecture.

Authors:  Sailen Barik
Journal:  J Biosci       Date:  2004-09       Impact factor: 1.826

5.  Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.

Authors:  Johann Soret; Nadia Bakkour; Sophie Maire; Sébastien Durand; Latifa Zekri; Mathieu Gabut; Weronika Fic; Gilles Divita; Christian Rivalle; Daniel Dauzonne; Chi Hung Nguyen; Philippe Jeanteur; Jamal Tazi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

6.  Optimization of SMN trans-splicing through the analysis of SMN introns.

Authors:  Monir Shababi; Christian L Lorson
Journal:  J Mol Neurosci       Date:  2011-08-09       Impact factor: 3.444

7.  Trans-splicing-mediated improvement in a severe mouse model of spinal muscular atrophy.

Authors:  Tristan H Coady; Christian L Lorson
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

8.  Correction of tau mis-splicing caused by FTDP-17 MAPT mutations by spliceosome-mediated RNA trans-splicing.

Authors:  Teresa Rodriguez-Martin; Karen Anthony; Mariano A Garcia-Blanco; S Gary Mansfield; Brian H Anderton; Jean-Marc Gallo
Journal:  Hum Mol Genet       Date:  2009-06-04       Impact factor: 6.150

9.  Exon exchange approach to repair Duchenne dystrophin transcripts.

Authors:  Stéphanie Lorain; Cécile Peccate; Maëva Le Hir; Luis Garcia
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

10.  Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo.

Authors:  Jun Wang; S Gary Mansfield; Colette A Cote; Ping Du Jiang; Ke Weng; Marcelo J A Amar; Bryan H Brewer; Alan T Remaley; Gerard J McGarrity; Mariano A Garcia-Blanco; M Puttaraju
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.